Please use this identifier to cite or link to this item:
https://doi.org/10.3390/cancers13215479
DC Field | Value | |
---|---|---|
dc.title | Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway | |
dc.contributor.author | Arora, Loukik | |
dc.contributor.author | Mohan, Chakrabhavi Dhananjaya | |
dc.contributor.author | Yang, Min Hee | |
dc.contributor.author | Rangappa, Shobith | |
dc.contributor.author | Deivasigamani, Amudha | |
dc.contributor.author | Kumar, Alan Prem | |
dc.contributor.author | Kunnumakkara, Ajaikumar B. | |
dc.contributor.author | Garg, Manoj | |
dc.contributor.author | Chinnathambi, Arunachalam | |
dc.contributor.author | Alharbi, Sulaiman Ali | |
dc.contributor.author | Alahmadi, Tahani Awad | |
dc.contributor.author | Rangappa, Kanchugarakoppal S. | |
dc.contributor.author | Hui, Kam Man | |
dc.contributor.author | Sethi, Gautam | |
dc.contributor.author | Ahn, Kwang Seok | |
dc.date.accessioned | 2022-10-13T01:11:23Z | |
dc.date.available | 2022-10-13T01:11:23Z | |
dc.date.issued | 2021-10-31 | |
dc.identifier.citation | Arora, Loukik, Mohan, Chakrabhavi Dhananjaya, Yang, Min Hee, Rangappa, Shobith, Deivasigamani, Amudha, Kumar, Alan Prem, Kunnumakkara, Ajaikumar B., Garg, Manoj, Chinnathambi, Arunachalam, Alharbi, Sulaiman Ali, Alahmadi, Tahani Awad, Rangappa, Kanchugarakoppal S., Hui, Kam Man, Sethi, Gautam, Ahn, Kwang Seok (2021-10-31). Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathway. Cancers 13 (21) : 5479. ScholarBank@NUS Repository. https://doi.org/10.3390/cancers13215479 | |
dc.identifier.issn | 2072-6694 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/232792 | |
dc.description.abstract | STAT3 is an oncogenic transcription factor that controls the expression of genes associated with oncogenesis and malignant progression. Persistent activation of STAT3 is observed in human. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | |
dc.publisher | MDPI | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | |
dc.source | Scopus OA2021 | |
dc.subject | Orthotopic | |
dc.subject | SHP2 | |
dc.subject | STAT3 signaling inhibitor | |
dc.subject | Tris DBA | |
dc.subject | Xenograft | |
dc.type | Article | |
dc.contributor.department | PHARMACOLOGY | |
dc.contributor.department | INSTITUTE OF MOLECULAR & CELL BIOLOGY | |
dc.description.doi | 10.3390/cancers13215479 | |
dc.description.sourcetitle | Cancers | |
dc.description.volume | 13 | |
dc.description.issue | 21 | |
dc.description.page | 5479 | |
Appears in Collections: | Elements Staff Publications |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_3390_cancers13215479.pdf | 26.41 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License